International market entry, without building an in-house export team
International expansion is not about sending products abroad.
It requires clarity on what to take, where to go, and how to structure distribution partnerships that work long-term.
Exporia supports healthcare companies through a structured, step-by-step market entry framework designed to reduce risk, preserve internal resources, and accelerate commercial traction.
A clear and sequential execution model
Portfolio & Export Readiness
We begin by assessing which products within your portfolio show the strongest potential for international expansion, considering differentiation, scalability, and market fit.
Market Prioritization
Rather than pursuing multiple markets simultaneously, Exporia helps identify and prioritize markets where your products are most likely to succeed, based on attractiveness and execution feasibility.
Partner Identification
Once priorities are defined, we identify and qualify potential distribution partners aligned with your portfolio, positioning, and long-term objectives.
Commercial Execution
Exporia manages commercial outreach and coordination, ensuring consistency and alignment with the agreed strategic framework. You remain informed and involved, without added operational burden.
Negotiation & Alignment
Commercial discussions are conducted within predefined boundaries to ensure coherence across markets, protect positioning, and accelerate decision-making.
Contract Finalization
Once terms are agreed, Exporia supports the transition from negotiation to execution, coordinating the final steps leading to a formal distribution agreement between your company and the selected partner.
Designed for clarity, control, and protection
No access to internal financial data
No access to product dossiers or intellectual property
No replacement of your internal commercial or regulatory teams
Exporia operates under clear confidentiality and scope agreements, ensuring full transparency and complete protection throughout the process.
